Effects of Oral Sildenafil on Mortality in Adults With PAH

NCT02060487 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

385

Enrollment

INDUSTRY

Sponsor class

Stopped Study was terminated by Sponsor at recommendation of Data Monitoring Committee after completion of first interim analysis as primary objective was met.

Conditions

Pulmonary Arterial Hypertension

Interventions

DRUG: sildenafil citrate
DRUG: sildenafil citrate
DRUG: sildenafil citrate

Sponsor

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.